跳至主要内容
临床试验/CTRI/2022/09/045406
CTRI/2022/09/045406尚未招募2 期

AProspective open lable clinical study to assess the safety and efficacy of Wesnil Plus in alcohol deaddiction

Shree Saptshrungi Nivasini Ayurvedic Company0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Chronic alcohol drinking history more than 3 years.
  • Alcohol withdrawal patients, including vomiting, nausea, tremors, anxiety, agitation etc. that had presented at that time.

排除标准

  • Nervous, Cardio, Vascular, Renal, Metabolic, etc.
  • - patients with h/o haematemisis, active PR bleeding and hoemorrhoids
  • - Patient who has clinical history of sensitivity of ingredients contains in
  • Wesnil Plus.
  • - Patient suffering from uncontrolled DM, HTN , Acute coronary Artery
  • diseases, Asthma & any other major illness.
  • - Patients on antitubercular and antiretroviral treatment.
  • - Patient whose heart, liver or kidney function is seriously abnormal.
  • - Patient who has participated in other clinical trial within
  • two months before starting these trials.

研究者

发起方
Shree Saptshrungi Nivasini Ayurvedic Company

相似试验